A CLINICAL STUDY ON SHWETHA PALANDU EYE DROP IN THE MANAGEMENT OF IMMATURE CATARACT

A TWO ARM RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED CLINICAL STUDY ON ANTI- CATARACT EFFECT OF SHWETHA PALANDU EYE DROP IN THE MANAGEMENT OF KAPHAJA TIMIRA (IMMATURE CATARACT)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025511

Enrollment

200

Registered

2020-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: Study Group- Shwetha Palandu Arka eye drops : Shwetha Palandu Arka - White variety onion distilled eye drop 3 drops 3 times daily for 60 days Control Intervention1: Jala Arka eye dro

Eligibility

Inclusion criteria

Inclusion criteria: Visual acuity of 6/60 or less Informed Consent Form

Exclusion criteria

Exclusion criteria: Patients with Senile Mature and Hyper mature Cataract Pregnant and Lactating mothers Congenital, developmental, traumatic, complicated or metabolic cataract Any other ocular pathology that can cause diminution of vision was excluded from the study

Design outcomes

Primary

Measure	Time frame
Visual acuity, Refraction, Direct opthalmoscopy, Auto refractometrey and slit lamp examinationTimepoint: Periodic follow up of the patients on 15th day, 30th day, 45th day, 60th day, 75th day, 90th day will be done.	—

Secondary

Measure	Time frame
Blurred vision, glare and floatersTimepoint: Periodic follow up of the patients on 15th day, 30th day, 45th day, 60th day, 75th day, 90th day will be done.	—

Countries

India

Contacts

Public ContactDR ASHWINI MJ

SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL, HASSAN

drashwinidhanpal@gmail.com9448222694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026